Pozhet Newsletter Autumn 2018
The Autumn edition of the Pozhet Client Newsletter has now been posted out. You […]
Blog 4 Column
Why a Great Sex Life with HIV Matters
“I am a PhD candidate and HIV-negative ally conducting sex-positive research with women living […]
Pozhet Drop-In Wednesday May 2nd
The next Pozhet Drop-In will be held on Wednesday May 2nd from 2-4pm, at […]
HIV in the media – fact or fiction?
It can be tricky when you’re searching online for information about HIV. You’ll find lots of […]
Pozhet Survey
In 2015, Pozhet conducted a survey asking heterosexual people living with HIV and their […]
Pozhet Retreat goes well!
Pozhet Workshop and Weekend Retreat Pozhet held our spring Retreat a few hours north […]
UK – harm reduction approach for breast feeding
Leading paediatrician, Dr Hermione Lyall of London told the British HIV Association (BHIVA) conference last week that although risk of HIV transmission when breast feeding was very low when viral load was supressed, there was not yet enough evidence to recommend “undetectable = untransmittable” (U=U). Dr Lyall recommended taking a harm reduction approach for women who wanted to breastfeed. (more…)
Reassurance for pregnant women regarding ART side effects
Most pregnant women are concerned about taking medications, particularly in the first 3 months (trimester) of a pregnancy as this is a particularly vulnerable time for the foetus. People with chronic conditions usually need to keep taking their treatments during pregnancy and it is important that they understand how the benefits balance against the risk of doing so. In high income countries such as Canada and Australia the transmission of HIV from an HIV positive woman to child is very low (less than 1%) and this is essentially due to Anti-retroviral therapy (ART). Recent research in Canada reviewed health related information from pregnant women over a period of 17 years up until 2015 and data from 214,240 pregnancies, of which 343 were HIV positive women was looked at. (more…)